BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 10, 2007
View Archived Issues
AMG-386/chemotherapy combination shows promise in cancer patients
Read More
Survival improved with ZD-4054 in prostate cancer patients with bone metastases
Read More
Esophageal tumor regression seen with NY-ESO-1 protein vaccine
Read More
Preclinical data on MOR-202, a fully human anti-CD38 MAb for the treatment of MM and leukemias
Read More
Shareholder approval sought in meeting for Peptech name change
Read More
Akesis seeks FDA approval to commence phase IIa evaluation of AKP-020 for type 2 diabetes
Read More
Jerini submits NDA for icatibant as HAE treatment
Read More
Peplin reports interim analysis of topical gel for AK
Read More
Camptothecin-incorporating micelles effective in stroma-rich pancreatic cancer
Read More
A novel KSP inhibitor by Merck & Co. shows activity in vivo
Read More
New agents for treating gastrointestinal disorders reported in recent patents
Read More
Novel diagnostic agents imparted in recent GE and Fujifilm patents
Read More
Recent Astellas patent discloses new therapeutic agents for benign prostatic hypertrophy
Read More
Phase III trial for low-dose formulation of Zenvia approved under SPA
Read More
Accentia nears IND submission for Revimmune
Read More
Horizon initiates follow-on phase III study of NSAID
Read More
Apatone successfully completes first clinical trial for treatment of cancer
Read More
Anacor Pharmaceuticals and GlaxoSmithKline to collaborate on boron-based therapeutics
Read More
New synthetic natriuretic peptide with in vivo activity for the treatment of heart failure
Read More
Cyclacel to acquire Align
Read More
Bind Biosciences awarded phase I SBIR grant for HRPC research
Read More
Improved lipid profile and insulin sensitivity by MBX-213, a novel dual PPARalpha/gamma agonist
Read More
Patient dosing begins in Jerini Ophthalmic phase I trial for age-related AMD
Read More
Living Cell Technologies reports promising initial data from DiabeCell phase I/II trial
Read More
Biothera commences I/II trial of Imprime PGG and MAb in metastatic colorectal cancer
Read More
